Data Infrastructure and Biological Modeling: The Public-Private Alliance for the Virtual Cell
Biohub, the scientific organization driven by Priscilla Chan and Mark Zuckerberg, announced the expansion of the Virtual Biology Initiative, a global alliance backed by $1.8 billion that brings together Big Tech and federal agencies in the United States to create a "virtual cell" powered by artificial intelligence. The initiative aims to transform experimental biology into a predictive discipline, allowing us to digitally anticipate how cells respond to drugs, diseases, and interventions before conducting laboratory tests.
At next+ we believe that the creation of the virtual cell represents the transition of artificial intelligence from content generation to deep scientific simulation. By bringing together the U.S. government’s public supercomputing infrastructure with the algorithms of Google DeepMind and Meta, the project lays the groundwork for a new paradigm in drug discovery: drastically reducing failure rates in pharmaceutical research by digitally discarding hypotheses. For leaders in biotechnology, health, and innovation, this open platform will transform corporate R&D models in the next five years.
Funding Structure and Capital Breakdown
The figure of $1.8 billion aggregates philanthropic capital, public supercomputing resources, and private investment in data and technology:
- Biohub (Chan Zuckerberg Initiative): Committed $500 million over five years, of which $400 million will be allocated to the development of biological measurement and manipulation technologies, and $100 million to external research.
- U.S. Department of Energy (DOE): Will contribute more than $500 million over five years, integrating access to national laboratories, advanced microscopy, and supercomputers.
- National Institutes of Health (NIH): Will provide standardized data repositories generated with over $500 million in prior federal investment.
- Google DeepMind, Isomorphic Labs, and Meta: Will jointly invest $300 million in computing capacity and algorithm development.
Overcoming the Bottleneck: Massive Data and Measurement Technology
Unlike text-based language models from the public internet, biology requires highly complex and structured data. A cell varies according to tissue, mutations, age, or medications. To address the shortage of standardized data, Biohub will use cryo-electron tomography, mass microscopy, and biological engineering to generate massive information about millions of cells.
The initiative plans to publish its first open dataset within a year and have functional predictive models within a five-year horizon.
Political Context and Biosafety Governance
The announcement comes eight days after a meeting at the White House between Donald Trump and tech leaders, including Mark Zuckerberg, to discuss AI infrastructure. Following that meeting, the participating companies agreed on voluntary safety principles aimed at preventing biosafety and cybersecurity risks in advanced models.